<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00894907</url>
  </required_header>
  <id_info>
    <org_study_id>DFG: HU 1707/2-1</org_study_id>
    <nct_id>NCT00894907</nct_id>
  </id_info>
  <brief_title>Early Goal-directed Volume Resuscitation in Severe Acute Pancreatitis</brief_title>
  <acronym>EAGLE</acronym>
  <official_title>EAGLE: Early Goal-directed Volume Resuscitation in Severe Acute Pancreatitis: A Randomised Multi-centre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universit채t M체nchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universit채t M체nchen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute pancreatitis (AP) is a common disorder with rising incidence varying between 35 and 80
      per 100,000 in Europe and the USA. About 15% of patients develop necrotizing pancreatitis
      (NP) with a mortality of up to 42% and frequently prolonged hospitalisation in the survivors.
      Despite a fulminant pathophysiology comparable to that of sepsis, the management of NP is
      still re-active, symptomatic and mainly based on paradigms with low grade evidence. In sepsis
      beneficial effects of early goal-directed fluid resuscitation resulting in reduced mortality
      have been clearly shown. With regard to these data and several studies of NP demonstrating
      the deleterious effects of fluid loss and haemoconcentration within the first 24h after
      admission, early goal-directed fluid resuscitation has the potential of improving outcome
      also in NP. Therefore, it is the aim of this RCT to demonstrate beneficial effects of early
      goal-directed resuscitation using an algorithm based on modern haemodynamic parameters such
      as Intra-thoracic Blood Volume Index (ITBI), Extravascular Lung Water Index (ELWI) and Stroke
      Volume Variation (SVV) which can be easily and safely obtained due to recent progress in
      haemodynamic monitoring. The algorithm is aimed at maintaining adequate resuscitation (ITBI,
      SVV) as well as preventing pulmonary over-hydration (ELWI).The use of a similar algorithm in
      cardiac surgery patients resulted in a significant reduction in catecholamine use, lactate
      levels, duration of ventilation and ICU stay.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Resuscitation using crystalloids and/or colloids with the following goals:

      ITBI: 850 -1000 ml/sqm, if ELWI &lt;=12*ml/kg 750 - 850 ml/sqm, if ELWI &gt;12*ml/kg and/or
      PaO2:FiO2 &lt;200

      *ELWI &lt;=12ml/kg, if MAP&gt;65mmHg without catecholamines &lt;=14ml/kg, if catecholamines required
      for MAP&gt;65mmHg SVV &lt;10% (only in controlled ventilation and sinus rhythm) MAP &gt;65mmHg (MAP:
      Mean Arterial Pressure) IAPP &gt;60mmHg (IAPP: Intra-abdominal Perfusion Pressure)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in APACHE II &gt;=4 within 4 days as compared to baseline (admission to ICU)</measure>
    <time_frame>4 days after admission to the ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>ICU-, 28-days- and in hospital mortality</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APACHE-II-Score</measure>
    <time_frame>4d; 7d; 28d</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of ICU-days</measure>
    <time_frame>Admission to transfer or death</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of organ failure within each group</measure>
    <time_frame>Time of ICU-stay</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>PiCCO-group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insertion of an arterial PiCCO catheter. Resuscitation using crystalloids and/or colloids according to PiCCO-parameter-guided algorithm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control: Haemodynamic management without ITBI and ELWI using any other haemodynamic monitoring tool, with the exception of the PiCCO-system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PiCCO-parameter-guided volume resuscitation</intervention_name>
    <description>Insertion of an arterial PiCCO catheter. Resuscitation using crystalloids and/or colloids with the following goals:
ITBI: 850-1000 ml/sqm, if ELWI &lt;=12*ml/kg; ITBI 750-850 ml/sqm, if ELWI &gt;12*ml/kg and/or PaO2:FiO2 &lt;200 (*ELWI&lt;=12ml/kg, if MAP&gt;65mmHg without catecholamines; ELWI&lt;=14ml/kg, if catecholamines required for MAP&gt;65mmHg); SVV&lt;10% (only in controlled ventilation and sinus rhythm); MAP&gt;65mmHg (MAP: Mean Arterial Pressure); IAPP &gt;60mmHg (IAPP: Intra-abdominal Perfusion Pressure)</description>
    <arm_group_label>PiCCO-group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control-group</intervention_name>
    <description>Haemodynamic management without ITBI and ELWI using any other haemodynamic monitoring tool, with the exception of the PiCCO-system.
Main haemodynamic goals: CVP 8-12 mmHg; MAP &gt;65mmHg;IAPP &gt;60mmHg</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of pancreatitis:

               -  Typical pain

               -  Increase in serum lipase or amylase

          2. Onset of abdominal pain within &lt;=48h before admission

          3. APACHE II &gt;= 8

          4. Evidence of &gt;= 1 predictor of severe pancreatitis:

               -  Haematocrit &gt;44% (male) or &gt;40% (female), respectively

               -  Blood glucose &gt; 125 mg/dl;

               -  CRP &gt;= 10 mg/dl;

               -  Age &gt; 55 years;

               -  Leukocytes &gt;= 16 G/L

               -  GOT &gt; 250 U/L;

               -  LDH &gt; 350 U/L

               -  Calcium &lt; 2,0 mmol/L

               -  CK &gt; upper normal range

               -  Balthazar-score(CT classification) Grade C-E

               -  Any organ failure

        Exclusion Criteria:

          1. Pregnancy

          2. NYHA &gt;II

          3. Pre-existing disease with life expectancy &lt; 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wolfgang Huber, MD</last_name>
    <phone>++49-89-4140-2265</phone>
    <email>Wolfgang.Huber@lrz.tum.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Medical Department; Klinikum Rechts der Isar</name>
      <address>
        <city>Munich</city>
        <zip>D-81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Huber, MD</last_name>
      <phone>++49-89-4140-2265</phone>
      <email>Wolfgang.Huber@lrz.tum.de</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Huber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Mair</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Huber W, Umgelter A, Reindl W, Franzen M, Schmidt C, von Delius S, Geisler F, Eckel F, Fritsch R, Siveke J, Henschel B, Schmid RM. Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water index. Crit Care Med. 2008 Aug;36(8):2348-54. doi: 10.1097/CCM.0b013e3181809928.</citation>
    <PMID>18596637</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2009</study_first_submitted>
  <study_first_submitted_qc>May 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2009</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Severe pancreatitis</keyword>
  <keyword>acute pancreatitis</keyword>
  <keyword>haemodynamic monitoring</keyword>
  <keyword>PiCCO</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

